Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Nivolumab
×
90 days
×
Clear all
Filters
3
NCT06097728
2026-03-04
eVOLVE-Meso
AstraZeneca
Phase 3
Recruiting
825 enrolled
NCT05136677
2026-01-23
CheckMate 6DW
Bristol-Myers Squibb
Phase 2
Completed
102 enrolled
NCT04334759
2026-01-22
DREAM3R
PrECOG, LLC.
Phase 3
Completed
214 enrolled